What is the 13F Pro Quality Score for CAH?

13F Pro ranks CARDINAL HEALTH INC (CAH) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View CAH's current score at https://13fpro.ai/company/CAH (free sign-up required for the full ranking).

Where does 13F Pro source CAH data?

All CARDINAL HEALTH INC fundamentals and ownership data come directly from SEC EDGAR. CARDINAL HEALTH INC files with the SEC under CIK 721371. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is CAH in?

CARDINAL HEALTH INC (CAH) is classified in the Consumer Staples sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/consumer-staples.

What are CAH's largest expenses?

CARDINAL HEALTH INC's latest 10-K reports these as the largest expense items: Cost of products sold ($244.5B, +14% YoY); Distribution, selling, general, and administrative expenses ($6.1B, +14% YoY); Amortization and other acquisition-related costs ($469M, +1% YoY). Sourced directly from SEC EDGAR filing text for FY2026 (year ended June 30, 2026).

How often is CAH research updated on 13F Pro?

CAH's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

CARDINAL HEALTH INC(CAH)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Consumer Staples →NYSElarge

Institutional-grade research for retail investors

SEC EDGAR: CIK 721371 CAH stock profile & AI dashboard →

13F Pro Quality Score

62.4/100

Rank #712 of 2,961 stocksTOP 25%

View Consumer Staples peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

49.7/100

Profitability

36.6/100

Balance Sheet

60.4/100

Earnings Quality

83.1/100

Free Cash Flow

33.2/100

Institutional Flow

78.1/100

Revenue Scale

99.5/100

Dilution Risk

86.9/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why CAH Scores 62/100

exact factor attribution · 2026-09-11

CAH's composite is driven by scale and earnings quality, held back by free cash flow and profitability. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Scale

+7.4 pts

100th pct

Earnings quality

+3.3 pts

83th pct

Earnings growth

+2.0 pts

90th pct

Shareholder dilution

+1.9 pts

87th pct

Institutional flow

+1.4 pts

78th pct

Capital efficiency

+1.0 pts

60th pct

Revenue growth

-0.1 pts

50th pct

Profitability

-2.0 pts

37th pct

Free cash flow

-2.5 pts

33th pct

Latest change (2026-08-13): 59 → 56 · ↓ Revenue growth 53→45; despite ↑ Institutional flow 30→41

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

CAH Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for CARDINAL HEALTH INC (CAH), a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores CAH at 62.4/100 on a 32-signal composite quality model, placing it at rank #712 of 2,961 stocks — the top 25% of the AI-ranked universe. CAH scores in the top quartile across revenue scale (99.5), earnings quality (83.1), institutional flow (78.1). Areas of concern include free cash flow (33.2) and profitability (36.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (FY 2026), CARDINAL HEALTH INC reports quarterly revenue of $254.2B, net income of $1.7B, an operating margin of 1.0%. Top institutional holders of CAH by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, WELLINGTON MANAGEMENT GROUP LLP, based on the most recent SEC filings. CAH trades on the NYSE exchange and files with the SEC under CIK 721371. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CAH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CARDINAL HEALTH INC directly from SEC EDGAR. CARDINAL HEALTH INC's 13F Pro composite quality score has ranged between 43 and 65 since 2021, currently 62.4 — an improving long-term trajectory across 68 quarterly and live scoring snapshots.

What's Driving CAH's Business? Latest 10-K Breakdown

AI-extracted from CARDINAL HEALTH INC's 10-K filed 2026-08-11 — FY2026 (year ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Cardinal Health revenue reached $254.2B (+14% YoY) driven by branded and specialty pharma growth; non-GAAP operating earnings grew 30% to $3.6B, though a $184M Navista & ION goodwill impairment and tariff headwinds tempered GAAP results.

Biggest Revenue Drivers

Pharmaceutical and Specialty Solutions$234.8B+15% YoY

Branded and specialty pharmaceutical sales growth from existing and new customers, plus MSO platform acquisitions.

Global Medical Products and Distribution$12.7B+1% YoY

Cardinal Health brand growth offset by lower distribution volumes and IEEPA tariff refund customer repayments.

Biggest Revenue Drivers

Total revenue: $254.2B+14% YoY

Pharmaceutical and Specialty Solutions$234.8B+15% YoY

Branded and specialty pharmaceutical sales growth from existing and new customers, plus MSO platform acquisitions.

Global Medical Products and Distribution$12.7B+1% YoY

Cardinal Health brand growth offset by lower distribution volumes and IEEPA tariff refund customer repayments.

Other$6.8B+26% YoY

Growth across at-Home Solutions including ADS acquisition, Nuclear and Precision Health Solutions, and OptiFreight Logistics.

Largest Expense Items

Cost of products sold$244.5B+14% YoY

Increased due to factors affecting revenue changes and gross margin performance.

Distribution, selling, general, and administrative expenses$6.1B+14% YoY

Increased primarily due to acquisitions of MSO platforms and ADS.

Amortization and other acquisition-related costs$469M+1% YoY

Amortization of acquisition-related intangible assets ($361M) and transaction/integration costs ($108M).

Margins: Gross margin increased 20% to $9.8B with a 17 basis point expansion driven by MSO acquisitions, increased branded and specialty pharma contributions, and strong generic program performance. However, margin rate benefited from higher-margin MSO businesses, partially offset by unfavorable product mix shifts from increased branded pharmaceutical distribution.

Watch Items from the Filing

CVS Health concentration: 28% of FY2026 revenue and 22% of gross receivables at June 30, 2026; loss would significantly impact operations.
Navista & ION goodwill impairment: $184M charge in Q3 FY2026 reflects reduced earnings expectations and increased discount rates; carrying value $909M remaining goodwill after impairment creates sensitivity to further declines.
Tariff exposure: ~$200M paid in IEEPA tariffs since Feb 2025 (primarily GMPD); $200M receivable recorded for expected government refunds; additional tariffs under other legal authorities continue to impact segment profit.
Five largest customers represent 43% of revenue; two largest GPO relationships (Vizient, Premier) represent 29% of revenue; customer concentration risk could materially impact results.
MSO acquisition integration: $1.9B Solaris Health acquisition completed Nov 2025 (post-period); integration risks and synergy realization remain, particularly given prior $184M impairment.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-K on SEC EDGAR →Share on X

Revenue

FY 2026

$254.2B

Net Income

FY 2026

$1.7B

Free Cash Flow

FY 2026

$4.5B

Operating Margin

FY 2026

1.0%

ROIC

FY 2026

43.5%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+14.2% YoY

$254.25BFY 2026

FY23 $204.98BFY24 $226.83BFY25 $222.58BFY26 $254.25B

Net Income

+9.8% YoY

$1.71BFY 2026

FY23 $330.0MFY24 $852.0MFY25 $1.56BFY26 $1.71B

Operating Income

+14.9% YoY

$2.61BFY 2026

FY23 $752.0MFY24 $1.24BFY25 $2.27BFY26 $2.61B

EPS (Diluted)

+12.1% YoY

$7.23FY 2026

FY23 $1.26FY24 $3.45FY25 $6.45FY26 $7.23

Total Assets

+7.9% YoY

$57.30BFY 2026

FY23 $43.42BFY24 $45.12BFY25 $53.12BFY26 $57.30B

Total Debt

+4.2% YoY

$8.89BFY 2026

FY23 $4.70BFY24 $5.10BFY25 $8.53BFY26 $8.89B

Op. Cash Flow

+115.9% YoY

$5.17BFY 2026

FY23 $2.84BFY24 $3.76BFY25 $2.40BFY26 $5.17B

Free Cash Flow

+144.6% YoY

$4.53BFY 2026

FY23 $2.36BFY24 $3.25BFY25 $1.85BFY26 $4.53B

Metric	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Revenue	$254.25B +14.2%	$222.58B -1.9%	$226.83B +10.7%	$204.98B +13.0%	$181.33B +11.6%	$162.47B
Net Income	$1.71B +9.8%	$1.56B +83.2%	$852.0M +158.2%	$330.0M +135.2%	$-938.0M -253.5%	$611.0M
Operating Income	$2.61B +14.9%	$2.27B +83.0%	$1.24B +65.3%	$752.0M +223.9%	$-607.0M -228.6%	$472.0M
EPS (Diluted)	$7.23 +12.1%	$6.45 +87.0%	$3.45 +173.8%	$1.26 +137.4%	$-3.37 -262.0%	$2.08
Total Assets	$57.30B +7.9%	$53.12B +17.7%	$45.12B +3.9%	$43.42B -1.1%	$43.88B -1.3%	$44.45B
Total Debt	$8.89B +4.2%	$8.53B +67.2%	$5.10B +8.5%	$4.70B -11.3%	$5.30B -14.5%	$6.20B
Operating Cash Flow	$5.17B +115.9%	$2.40B -36.3%	$3.76B +32.3%	$2.84B -10.4%	$3.17B +30.7%	$2.43B
Free Cash Flow	$4.53B +144.6%	$1.85B -43.1%	$3.25B +37.6%	$2.36B -15.2%	$2.79B +37.4%	$2.03B

Get alerted when CAH's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for CARDINAL HEALTH INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of CAH

BlackRock, Inc.
$6.3B26,490,633 sh
VANGUARD CAPITAL MANAGEMENT LLC
$3.6B15,292,186 sh
WELLINGTON MANAGEMENT GROUP LLP
$3.5B14,860,271 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$3.3B13,717,894 sh
STATE STREET CORP
$2.8B11,967,121 sh
GEODE CAPITAL MANAGEMENT, LLC
$1.5B6,472,810 sh
Invesco Ltd.
$1.1B4,742,576 sh
MORGAN STANLEY
$1.1B4,625,329 sh
WCM INVESTMENT MANAGEMENT, LLC
$971.4M4,112,461 sh
NORGES BANK
$885.2M3,726,422 sh

Fund	Value	Shares
BlackRock, Inc.	$6.3B	26,490,633
VANGUARD CAPITAL MANAGEMENT LLC	$3.6B	15,292,186
WELLINGTON MANAGEMENT GROUP LLP	$3.5B	14,860,271
VANGUARD PORTFOLIO MANAGEMENT LLC	$3.3B	13,717,894
STATE STREET CORP	$2.8B	11,967,121
GEODE CAPITAL MANAGEMENT, LLC	$1.5B	6,472,810
Invesco Ltd.	$1.1B	4,742,576
MORGAN STANLEY	$1.1B	4,625,329
WCM INVESTMENT MANAGEMENT, LLC	$971.4M	4,112,461
NORGES BANK	$885.2M	3,726,422

Companies Similar to CAH

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

COR

Cencora, Inc.

AI score

Very similar · 43 shared holders

NORDEA INVESTMENT MANAGEMENT AB Swedbank AB National Pension Service

MCK

MCKESSON CORP

AI score

Very similar · 38 shared holders

WCM INVESTMENT MANAGEMENT, LLC NORDEA INVESTMENT MANAGEMENT AB Robeco Institutional Asset Management B.V.

CTVA

Corteva, Inc.

AI score

Very similar · 31 shared holders

WCM INVESTMENT MANAGEMENT, LLC Swedbank AB National Pension Service

PEP

PEPSICO INC

AI score

Very similar · 36 shared holders

NORDEA INVESTMENT MANAGEMENT AB Robeco Institutional Asset Management B.V.1832 Asset Management L.P.

MDLZ

Mondelez International, Inc.

AI score

Shared smart-money ownership · 29 shared holders

NORDEA INVESTMENT MANAGEMENT AB National Pension Service 1832 Asset Management L.P.

COCA COLA CO

AI score

Shared smart-money ownership · 36 shared holders

NORDEA INVESTMENT MANAGEMENT AB Robeco Institutional Asset Management B.V.Swedbank AB

MNST

Monster Beverage Corp

AI score

Shared smart-money ownership · 38 shared holders

Robeco Institutional Asset Management B.V.National Pension Service 1832 Asset Management L.P.

PROCTER & GAMBLE Co

AI score

Shared smart-money ownership · 37 shared holders

NORDEA INVESTMENT MANAGEMENT AB Swedbank AB 1832 Asset Management L.P.

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Consumer Staples Companies

View all Consumer Staples →

ABEV

AMBEV S.A.

ABVE

Above Food Ingredients Inc.

ACI

Albertsons Companies, Inc.

ADM

Archer-Daniels-Midland Co

AFRI

Forafric Global PLC

AGCC

Agencia Comercial Spirits Ltd.

AGRO

Adecoagro S.A.

AGRZ

Agroz Inc.

Put CAH on your watchlist

Track score changes the day CARDINAL HEALTH INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is CAH a good stock to buy?

13F Pro's AI-powered analysis of CARDINAL HEALTH INC (CAH) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Consumer Staples sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CAH are available on the CAH stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CAH is classified as a large company.

Which hedge funds own CAH?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CAH. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CARDINAL HEALTH INC's investment landscape.